This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Global Superbugs Herald Age of Silver

The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.

NEW YORK ( Bullion Bulls Canada) -- For several years I have been touting silver's unique anti-microbial properties. Out of the nearly infinite list of technological/industrial applications for silver, it always seemed inevitable to me that this one use would ultimately become our single greatest need for the Metal of the Moon.

That suspicion could, in turn, be traced back to a single threat that has loomed ever larger, ever more menacing: superbugs. This is the colloquial name given to the bacterial monsters we have created through the reckless, excessive and simply idiotic manner in which our species has overused its single most important medicine: antibiotics.

Most readers are already familiar with the path that led us to what the World Health Organization is now openly labeling as the world's "post-antibiotic era." For those not suitably terrified by the ominous meaning of those words, read this quote from WHO Director-General Margaret Chan: "Things as common as strep throat or a child's scratched knee could once again kill."

Follow TheStreet on Twitter and become a fan on Facebook.

This is not hyperbole, as a chilling article in Bloomberg makes clear. The article identifies a newly discovered gene that exhibits two terrifying features: it renders bacteria invulnerable to antibiotics and it can transform virtually any type of bacteria into a new superbug. The bubonic plague and cholera are only two that are mentioned.

Fortunately, ingenuity has provided us with a means to mitigate this medical catastrophe: silver anti-microbial technology. While the relentless over-use of antibiotics has ruined their effectiveness, scientists have been systematically designing silver-based applications to protect us from these killers. These are not treatments, but can be used to create anti-bacterial clothing and surfaces to help prevent diseases from spreading.

Given the significant increase in the price of silver over the past decade, many readers may view the creation of a partial "silver shield" around us as prohibitively expensive. But silver is only a tiny component in these products, as literally microscopic amounts are sufficient to convey this anti-bacterial protection, less than 1/1,000th part silver (by weight).

Antibiotics and silver-based anti-microbial products fight bacteria in entirely different manners. Antibiotics essentially poison each individual bacteria cell. The substance is ingested by the bacteria and takes time to kill each and every cell.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FB $80.55 -0.81%
GOOG $571.31 -0.70%
TSLA $197.02 -1.80%
YHOO $43.85 -0.70%
AAPL $127.72 1.00%

Markets

DOW 17,949.68 -186.04 -1.03%
S&P 500 2,083.26 -17.78 -0.85%
NASDAQ 4,954.2340 -28.5750 -0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs